Cork is the second largest city in Republic of Ireland and third largest in the island of Ireland located in the south-west of Ireland, in the province of Munster. Following an extension to the city's boundary in 2019, its population is c. 210,000.

During the past decade, University College Cork conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University College Cork" #1 sponsor was "University College Cork" with 10 trials, followed by "CancerVax Corporation" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Medical University of Graz" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University College Cork" #1 collaborator was "Queen's University, Belfast" with 2 trials as a collaborator, "Teagasc" with 2 trials as a collaborator, "University College Cork" with 2 trials as a collaborator, "University College Dublin" with 2 trials as a collaborator and "Alzheimer Europe" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University College Cork" are "Dietary Habits" (2 trials), "Malignant Melanoma" (2 trials), "Alzheimer's Disease" (1 trials), "Birth Hypoxia" (1 trials) and "Body Weight" (1 trials). Many other conditions were trialed in "University College Cork" in a lesser frequency.

Most popular intervention types in "University College Cork" are "Behavioral" (4 trials), "Dietary Supplement" (4 trials), "Drug" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "CancerVax vaccine (CANVAXIN)" (2 trials), "Placebo" (2 trials), "25-hydroxyvitamin D (20 microgram/day)" (1 trials), "25-hydroxyvitamin D3" (1 trials) and "Aquamin/Aquamin MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "University College Cork" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University College Cork". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University College Cork, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University College Cork, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".

University College Cork has several departments that took part in Clinical trials: "Brian O'Donnell" - 2 trials, "Cork University Dental School and Hospital" - 2 trials, "Dept. of Medicine (Geriatrics), University College Cork" - 2 trials, "Alimentary Pharmabiotic Centre, University College Cork" - 2 trials